Journal of Neuromuscular Diseases Celebrates 10-Year Anniversary with Commemorative Editorial
The January 2024 edition of the Journal of Neuromuscular Diseases (JND) marked the journal’s 10-year anniversary! This is a special milestone for the publication that serves the international community as a publication for neuromuscular translational research, aiming to facilitate progress in understanding the molecular genetics/correlates, pathogenesis, pharmacology, diagnosis and treatment of acquired and genetic neuromuscular disease.
In recognition of this occasion, Co-Editors-in-Chief of the JND, Dr. Hanns Lochmüller and Dr. Carsten Bonnëmann have published the editorial “The First Decade of Journal of Neuromuscular Diseases: Supporting and Advancing the Rapidly Evolving Field of Translational Research”, a review of the evolution of the JND from conception to current day.
Highlights from the editorial include:
- Remarks on the initial need for the journal
- Benchmarks of the journal’s impact and growth
- A content summary of JND publications by disease type, demographics, and research methodologies
- Discussion on recent trends, inspiration, and hope for the future of translational neuromuscular research
The entire team at the JND are proud to have been part of the past decade of exciting advancements in preclinical and clinical translational neuromuscular research, and look forward to another decade of growing the journal and serving the neuromuscular community.
Read next...
Discover Neuromuscular Talent Across Canada
The NMD4C Neuromuscular Talent Pool is now live with new trainees! We invite supervisors and research groups to explore the Talent Pool to identify candidates whose skills, experience, and interests align with your work and upcoming positions. Trainees interested in being included in the Neuromuscular Talent Pool can register by completing the short form, uploading a CV and brief personal statement outlining their experience, interests, and career goals. For more information and to access the Talent Pool, please visit our website.
Join Us at the 2026 NMD4C Annual Meeting on 25 September
The 2026 NMD4C Annual Meeting will take place in Calgary on Friday, September 25, 2026. The agenda will feature a brief network update, trainee and early-career recognitions, flash talks, a health economics research showcase, and a series of cross‑disciplinary and parallel clinical/pre‑clinical discussion sessions to explore key topics, including advocacy and therapy access, strategies to sustain and strengthen pre-clinical programs, and network sustainability and strategic planning.
Introducing Our New SOP on Skeletal Muscle Fiber Typing
We are excited to announce the release of our latest Standard Operating Procedure (SOP) titled “Skeletal Muscle Fiber Typing & Cross-Sectional Area Analysis using Immunofluorescence Staining for Mice,” developed by from our Basic Science Trainee Committee (BSTC) member Shatha Atieh, Phd Student at uOttawa. This SOP aims to provide a comprehensive, step-by-step protocol for staining and analyzing skeletal muscle fibers from any muscle group in various mouse models. This new SOP provides detailed methods for immunofluorescence‑based fiber typing using MyHC‑I, MyHC‑IIA, MyHC‑IIB, and laminin, enabling accurate assessment of fiber‑type composition and cross‑sectional area (CSA).